Placental fas/fas ligand expression in early pregnancy losses

Am J Reprod Immunol. 2008 Jul;60(1):1-7. doi: 10.1111/j.1600-0897.2008.00583.x. Epub 2008 Apr 1.

Abstract

Problem: The aim of this study was to compare the expression levels of Fas and Fas ligand (FasL) in first-trimester placentas obtained from spontaneous abortions in patients with antiphospholipid antibody syndrome (APS) or factor V (FV) Leiden mutation, compared with values in placentas from induced abortions in patients negative for these conditions.

Method of study: We studied explants from 6- to 10-week-old placentas that had been prepared by collagenase digestion from 10 spontaneous abortions from APS-positive patients, nine spontaneous abortions in patients positive for FV Leiden mutation, and 10 induced abortions. All tissues were analyzed by flow cytometry for expression of Fas and FasL.

Results: Flow cytometric analysis showed that placental FasL expression was significantly lower in abnormal pregnancies than in normal ones. However, no such difference was observed for Fas expression.

Conclusion: FasL on placental cells may be involved in the maintenance of immune privilege, thereby ensuring the safety and growth of placental tissues. Dysregulation of apoptotic mechanisms may play a critical role in spontaneous abortions.

MeSH terms

  • Abortion, Spontaneous / etiology
  • Abortion, Spontaneous / metabolism*
  • Antiphospholipid Syndrome / complications
  • Factor V / metabolism
  • Fas Ligand Protein / biosynthesis*
  • Female
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Humans
  • Immune Tolerance / physiology
  • Placenta / metabolism*
  • Pregnancy
  • Pregnancy Trimester, First
  • fas Receptor / biosynthesis*

Substances

  • Fas Ligand Protein
  • factor V Leiden
  • fas Receptor
  • Factor V